Enanta Pharmaceuticals ENTA Stock
5.58 USD
{{ price }}
-1.587304%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
120.96M USD
LOW - HIGH [24H]
5.39
-
5.7 USD
VOLUME [24H]
176.71K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-4.95 USD
Enanta Pharmaceuticals Price Chart
Enanta Pharmaceuticals ENTA Financial and Trading Overview
| Enanta Pharmaceuticals stock price | 5.58 USD |
| Previous Close | 23.8 USD |
| Open | 23.6 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1100 |
| Day's Range | 23.19 - 24.2 USD |
| 52 Week Range | 22.8 - 76.36 USD |
| Volume | 157.64K USD |
| Avg. Volume | 203.92K USD |
| Market Cap | 509.12M USD |
| Beta (5Y Monthly) | 0.384859 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.95 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.13 USD |
ENTA Valuation Measures
| Enterprise Value | 328.45M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.5402637 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.2717996 |
| Price/Book (mrq) | 1.8893577 |
| Enterprise Value/Revenue | 4.046 |
| Enterprise Value/EBITDA | -2.594 |
Trading Information
Enanta Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.384859 |
| 52-Week Change | -40.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 76.36 USD |
| 52 Week Low | 22.8 USD |
| 50-Day Moving Average | 30.58 USD |
| 200-Day Moving Average | 43.78 USD |
ENTA Share Statistics
| Avg. Volume (3 month) | 203.92K USD |
| Avg. Daily Volume (10-Days) | 178K USD |
| Shares Outstanding | 21.06M |
| Float | 16.09M |
| Short Ratio | 3.1 |
| % Held by Insiders | 6.59% |
| % Held by Institutions | 93.65% |
| Shares Short | 789.59K |
| Short % of Float | 4.83% |
| Short % of Shares Outstanding | 3.75% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | -153.60% |
| Operating Margin (ttm) | -158.97% |
| Gross Margin | 100.00% |
| EBITDA Margin | -155.99% |
Management Effectiveness
| Return on Assets (ttm) | -22.00000000000000000000000000000000% |
| Return on Equity (ttm) | -39.71% |
Income Statement
| Revenue (ttm) | 81.18M USD |
| Revenue Per Share (ttm) | 3.9 USD |
| Quarterly Revenue Growth (yoy) | -4.90% |
| Gross Profit (ttm) | 86.16M USD |
| EBITDA | -126630000 USD |
| Net Income Avi to Common (ttm) | -124692000 USD |
| Diluted EPS (ttm) | -5.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 210.08M USD |
| Total Cash Per Share (mrq) | 9.98 USD |
| Total Debt (mrq) | 29.42M USD |
| Total Debt/Equity (mrq) | 10.92 USD |
| Current Ratio (mrq) | 8.429 |
| Book Value Per Share (mrq) | 12.798 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -94560000 USD |
| Levered Free Cash Flow (ttm) | -56517500 USD |
Profile of Enanta Pharmaceuticals
| Country | United States |
| State | MA |
| City | Watertown |
| Address | 500 Arsenal Street |
| ZIP | 02472 |
| Phone | 617 607 0800 |
| Website | https://www.enanta.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 160 |
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.
Q&A For Enanta Pharmaceuticals Stock
What is a current ENTA stock price?
Enanta Pharmaceuticals ENTA stock price today per share is 5.58 USD.
How to purchase Enanta Pharmaceuticals stock?
You can buy ENTA shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enanta Pharmaceuticals?
The stock symbol or ticker of Enanta Pharmaceuticals is ENTA.
Which industry does the Enanta Pharmaceuticals company belong to?
The Enanta Pharmaceuticals industry is Biotechnology.
How many shares does Enanta Pharmaceuticals have in circulation?
The max supply of Enanta Pharmaceuticals shares is 21.68M.
What is Enanta Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Enanta Pharmaceuticals PE Ratio is now.
What was Enanta Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Enanta Pharmaceuticals EPS is -4.95 USD over the trailing 12 months.
Which sector does the Enanta Pharmaceuticals company belong to?
The Enanta Pharmaceuticals sector is Healthcare.
Enanta Pharmaceuticals ENTA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Composite Total Return I XCMP | 21278.67 USD — |
+1.26
|
— — | 20945.45 USD — | 21305.05 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4148.65 USD — |
+0.54
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4470.08 USD — |
-1.41
|
— — | 4446.23 USD — | 4506.67 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4131.38 USD — |
-1.41
|
— — | 4109.33 USD — | 4165.2 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}